By James Illman2016-10-24T00:01:00
Patient access to some innovative drugs and other interventions could be brought forward by up to four years by restructuring the NHS’s approval and adoption process, a government commissioned review has concluded.
With a HSJ subscription you’ll unlock:
Already a subscriber? Sign into your account here
Part of HSJ Information Ltd. The White Chapel Building, 1st Floor, 10 Whitechapel High Street, London, E1 8QS. Registered in England and Wales. Company registration 2530185
Site powered by Webvision Cloud